Goserelin (Zoladex ) depot in the treatment of endometriosis
- 1 June 1992
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 57 (6) , 1197-1202
- https://doi.org/10.1016/s0015-0282(16)55073-0
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical resultsFertility and Sterility, 1990
- Ovarielle Suppression durch das GnRH-Analogon Buserelin zur Behandlung der EndometrioseGeburtshilfe und Frauenheilkunde, 1990
- Efficacy and safety of nafarelin in the treatment of endometriosisAmerican Journal of Obstetrics and Gynecology, 1990
- Administration of nasal Buserelin as compared with subcutaneous Buserelin implant for endometriosisFertility and Sterility, 1989
- Endometriosis: treatment with gonadotropin-releasing hormone agonist BuserelinFertility and Sterility, 1989
- Administration of Nasal Nafarelin as Compared with Oral Danazol for EndometriosisNew England Journal of Medicine, 1988
- Revised American Fertility Society Classification of Endometriosis: 1985Fertility and Sterility, 1985
- Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosisFertility and Sterility, 1984
- Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis.BMJ, 1983
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS.Journal of Clinical Endocrinology & Metabolism, 1982